vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and LIVEPERSON INC (LPSN). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $59.3M, roughly 1.6× LIVEPERSON INC). LIVEPERSON INC runs the higher net margin — -77.8% vs -98.1%, a 20.3% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs -19.0%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs -16.6%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

LivePerson is a global technology company that develops conversational commerce and AI software.

HIVE vs LPSN — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.6× larger
HIVE
$93.1M
$59.3M
LPSN
Growing faster (revenue YoY)
HIVE
HIVE
+237.6% gap
HIVE
218.6%
-19.0%
LPSN
Higher net margin
LPSN
LPSN
20.3% more per $
LPSN
-77.8%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
-16.6%
LPSN

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
LPSN
LPSN
Revenue
$93.1M
$59.3M
Net Profit
$-91.3M
$-46.1M
Gross Margin
-27.1%
73.2%
Operating Margin
-68.7%
Net Margin
-98.1%
-77.8%
Revenue YoY
218.6%
-19.0%
Net Profit YoY
-234.0%
58.9%
EPS (diluted)
$-0.38
$-9.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
LPSN
LPSN
Q4 25
$93.1M
$59.3M
Q3 25
$87.3M
$60.2M
Q2 25
$45.6M
$59.6M
Q1 25
$64.7M
Q4 24
$29.2M
$73.2M
Q3 24
$22.6M
$74.2M
Q2 24
$32.2M
$79.9M
Q1 24
$85.1M
Net Profit
HIVE
HIVE
LPSN
LPSN
Q4 25
$-91.3M
$-46.1M
Q3 25
$-15.8M
$8.7M
Q2 25
$35.0M
$-15.7M
Q1 25
$-14.1M
Q4 24
$68.2M
$-112.1M
Q3 24
$80.0K
$-28.3M
Q2 24
$-18.3M
$41.8M
Q1 24
$-35.6M
Gross Margin
HIVE
HIVE
LPSN
LPSN
Q4 25
-27.1%
73.2%
Q3 25
4.7%
71.4%
Q2 25
-13.6%
69.7%
Q1 25
71.8%
Q4 24
-43.7%
77.4%
Q3 24
-66.1%
73.1%
Q2 24
-7.4%
79.4%
Q1 24
71.3%
Operating Margin
HIVE
HIVE
LPSN
LPSN
Q4 25
-68.7%
Q3 25
-24.2%
Q2 25
-10.8%
Q1 25
-26.2%
Q4 24
-138.0%
Q3 24
-21.6%
Q2 24
-37.3%
Q1 24
-42.7%
Net Margin
HIVE
HIVE
LPSN
LPSN
Q4 25
-98.1%
-77.8%
Q3 25
-18.1%
14.5%
Q2 25
76.8%
-26.4%
Q1 25
-21.8%
Q4 24
233.2%
-153.2%
Q3 24
0.4%
-38.1%
Q2 24
-56.7%
52.3%
Q1 24
-41.8%
EPS (diluted)
HIVE
HIVE
LPSN
LPSN
Q4 25
$-0.38
$-9.22
Q3 25
$-0.07
$-2.76
Q2 25
$0.18
$-0.17
Q1 25
$-0.24
Q4 24
$0.52
$-17.23
Q3 24
$0.00
$-4.74
Q2 24
$-0.17
$-0.33
Q1 24
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
LPSN
LPSN
Cash + ST InvestmentsLiquidity on hand
$95.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$-44.5M
Total Assets
$624.0M
$454.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
LPSN
LPSN
Q4 25
$95.0M
Q3 25
$106.7M
Q2 25
$162.0M
Q1 25
$176.3M
Q4 24
$40.5M
$183.2M
Q3 24
$31.7M
$142.1M
Q2 24
$146.0M
Q1 24
$127.1M
Total Debt
HIVE
HIVE
LPSN
LPSN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$512.1M
Stockholders' Equity
HIVE
HIVE
LPSN
LPSN
Q4 25
$559.3M
$-44.5M
Q3 25
$624.6M
$-22.1M
Q2 25
$560.5M
$-82.4M
Q1 25
$-74.9M
Q4 24
$430.9M
$-67.3M
Q3 24
$275.5M
$45.9M
Q2 24
$268.6M
$66.6M
Q1 24
$19.2M
Total Assets
HIVE
HIVE
LPSN
LPSN
Q4 25
$624.0M
$454.7M
Q3 25
$693.0M
$511.4M
Q2 25
$628.7M
$604.2M
Q1 25
$596.2M
Q4 24
$478.6M
$607.8M
Q3 24
$334.7M
$692.0M
Q2 24
$703.8M
Q1 24
$724.7M
Debt / Equity
HIVE
HIVE
LPSN
LPSN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
26.69×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
LPSN
LPSN
Operating Cash FlowLast quarter
$46.0M
$-9.7M
Free Cash FlowOCF − Capex
$-12.0M
FCF MarginFCF / Revenue
-20.2%
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
LPSN
LPSN
Q4 25
$46.0M
$-9.7M
Q3 25
$-10.6M
$-6.0M
Q2 25
$10.2M
$-11.7M
Q1 25
$-3.1M
Q4 24
$-28.5M
$-3.1M
Q3 24
$-2.2M
$4.8M
Q2 24
$-4.4M
$-17.9M
Q1 24
$1.1M
Free Cash Flow
HIVE
HIVE
LPSN
LPSN
Q4 25
$-12.0M
Q3 25
$-8.9M
Q2 25
$-14.8M
Q1 25
$-6.9M
Q4 24
$-55.5M
$-6.8M
Q3 24
$-34.7M
$-230.0K
Q2 24
$-22.9M
Q1 24
$-10.4M
FCF Margin
HIVE
HIVE
LPSN
LPSN
Q4 25
-20.2%
Q3 25
-14.8%
Q2 25
-24.9%
Q1 25
-10.6%
Q4 24
-189.9%
-9.2%
Q3 24
-153.4%
-0.3%
Q2 24
-28.7%
Q1 24
-12.2%
Capex Intensity
HIVE
HIVE
LPSN
LPSN
Q4 25
3.9%
Q3 25
4.8%
Q2 25
5.3%
Q1 25
5.8%
Q4 24
92.5%
5.0%
Q3 24
143.9%
6.8%
Q2 24
6.2%
Q1 24
13.5%
Cash Conversion
HIVE
HIVE
LPSN
LPSN
Q4 25
Q3 25
-0.69×
Q2 25
0.29×
Q1 25
Q4 24
-0.42×
Q3 24
-26.94×
Q2 24
-0.43×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIVE
HIVE

Segment breakdown not available.

LPSN
LPSN

Hosted Services Business$51.0M86%
Professional Services$8.3M14%

Related Comparisons